Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 16 filers reported holding Astellas Pharma Inc in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $235,000 | -5.2% | 14,222 | 0.0% | 0.07% | +4.2% |
| Q2 2021 | $248,000 | +13.2% | 14,222 | 0.0% | 0.07% | +7.6% |
| Q1 2021 | $219,000 | -0.5% | 14,222 | 0.0% | 0.07% | -14.3% |
| Q4 2020 | $220,000 | +4.3% | 14,222 | 0.0% | 0.08% | -10.5% |
| Q3 2020 | $211,000 | -27.2% | 14,222 | -18.3% | 0.09% | -28.9% |
| Q2 2020 | $290,000 | +6.2% | 17,402 | -1.5% | 0.12% | -13.6% |
| Q1 2020 | $273,000 | -10.2% | 17,669 | 0.0% | 0.14% | +18.6% |
| Q4 2019 | $304,000 | +20.6% | 17,669 | 0.0% | 0.12% | +10.3% |
| Q3 2019 | $252,000 | 0.0% | 17,669 | 0.0% | 0.11% | -0.9% |
| Q2 2019 | $252,000 | -7.0% | 17,669 | -2.3% | 0.11% | -12.2% |
| Q1 2019 | $271,000 | +17.3% | 18,078 | 0.0% | 0.12% | -18.0% |
| Q4 2018 | $231,000 | -12.2% | 18,078 | +20.1% | 0.15% | +51.5% |
| Q3 2018 | $263,000 | – | 15,052 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| THOMAS WHITE INTERNATIONAL LTD | 339,011 | $5,024,000 | 0.72% |
| GRATRY & Co LLC | 83,750 | $1,243,000 | 0.41% |
| GlobalBridge, Inc. | 14,392 | $213,000 | 0.11% |
| Aperio Group, LLC | 454,127 | $6,729,000 | 0.10% |
| ZEVIN ASSET MANAGEMENT LLC | 18,581 | $276,000 | 0.08% |
| ETRADE Capital Management LLC | 63,601 | $942,000 | 0.07% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 411,463 | $6,106,000 | 0.02% |
| PRIVATE TRUST CO NA | 456 | $7,000 | 0.00% |
| First Horizon Advisors, Inc. | 290 | $4,000 | 0.00% |
| AMERIPRISE FINANCIAL INC | 10,929 | $163,000 | 0.00% |